Ang Lifesciences reappoints Chetna as Independent Director for 5 years

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Shareholders approved Mrs. Chetna's reappointment as Independent Director for a second five-year term
  • New term runs from October 12, 2026, to October 11, 2031
  • Meeting adopted FY26 financial statements and ratified cost auditor remuneration for FY27
  • 38 members participated in the video-conferenced AGM, satisfying quorum requirements
powered bylight_fuzz_icon
52327396

*this image is generated using AI for illustrative purposes only.

ANG Lifesciences India Limited shareholders approved the reappointment of Mrs. Chetna as an Independent Director for a second term of five years during the company's 20th Annual General Meeting held on September 30, 2026.

The new term commences on October 12, 2026, and extends through October 11, 2031. The appointment was ratified under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following a prior intimation dated September 7, 2026.

AGM proceedings and resolutions

The meeting was chaired by Managing Director Rajesh Gupta and conducted via video conferencing. Independent Director Sukhpal Singh was granted leave of absence due to unavoidable circumstances, while five other directors, including Wholetime Director and CFO Saruchi Gupta, attended virtually. A total of 38 members participated, satisfying quorum requirements.

Key resolutions passed included:

  • Adoption of audited standalone and consolidated financial statements for FY26.
  • Re-appointment of Rohit Mittal as a director retiring by rotation.
  • Ratification of the cost auditor's remuneration for FY27.
  • Re-appointment of Chetna as an independent director.

The company noted that no queries were received from shareholders during the session. The meeting commenced at 12:00 pm and concluded at 12:22 pm.

Director profile and compliance details

Mrs. Chetna (DIN: 08981045) brings extensive experience in corporate law, securities law, SEBI compliances, financial management, accounts, and taxation. Her qualifications include an LLB from Jaipur School of Law, Company Secretary certification from the Institute of Company Secretaries of India, and an MBA in Finance. She is registered in the Independent Director Databank under the Indian Institute of Corporate Affairs.

Particulars Details
Name Mrs. Chetna
DIN 08981045
Role Independent Director
Term Start October 12, 2026
Term End October 11, 2031
Duration 5 years

Disclosure records indicate no relationship between Mrs. Chetna and other Directors or Key Managerial Personnel. She is not debarred from holding the office of Director by any SEBI order or authority.

Voting and compliance

Remote e-voting facilities were available to members from September 27, 2026, to September 29, 2026. Additionally, e-voting was enabled during the AGM for those who had not voted remotely. The scrutinizer, Anil Negi, will submit the consolidated voting results to the stock exchanges within two working days. The results will also be placed on the company's website.

Historical Stock Returns for ANG Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
+1.86%+7.98%+33.25%+112.33%+27.65%-84.61%

How will Mrs. Chetna's continued tenure as an Independent Director influence ANG Lifesciences' strategic compliance posture regarding upcoming SEBI regulatory changes?

What specific governance improvements or board-level initiatives are expected to emerge from the stability provided by the reappointment of key directors for the FY27-FY31 period?

Given the rapid conclusion of the AGM with no shareholder queries, how might this signal affect institutional investor confidence in the company's current communication transparency?

ANG Lifesciences fixes AGM date, approves director re-appointments

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • ANG Lifesciences fixes 20th AGM for September 30, 2026
  • Book closure runs from September 24 to September 30, 2026
  • Board approves re-appointment of Mr. Rohit Mittal by rotation
  • Mrs. Chetna re-appointed as Independent Director for five years
powered bylight_fuzz_icon
50357210

*this image is generated using AI for illustrative purposes only.

ANG Lifesciences India Limited held its board meeting on September 7, 2026, to approve the re-appointment of key directors and fix the date for its upcoming annual general meeting.

The board approved the proposal to re-appoint Mr. Rohit Mittal, who is due to retire by rotation under Section 152(6) of the Companies Act, 2013. His re-appointment will be placed before shareholders for approval at the ensuing AGM.

Board Approvals and AGM Details

The board fixed the date for the 20th Annual General Meeting (AGM) as September 30, 2026, at 12:00 pm. The meeting will be conducted through Video Conference or Other Audio-Visual Mode (VC/OAVM).

Key logistical details for the AGM include:

  • Book Closure Period: September 24, 2026, to September 30, 2026 (both days inclusive).
  • Cut-off Date: September 23, 2026, for determining members eligible to vote on resolutions.
  • Scrutinizer: M/s Anil Negi & Company, Practicing Company Secretary, was appointed to scrutinize e-voting.

The board also considered and approved the appointment of M/s Shreya Sahu & Associates (FRN 101389) as Cost Auditor for FY27. Additionally, the board approved the Board’s report along with annexures for FY26.

Director Re-appointment

Based on the recommendation of the Nomination and Remuneration Committee, the board approved the re-appointment of Mrs. Chetna (DIN: 08981045) as an Independent Director. This marks her second term, which will run for five consecutive years from October 12, 2026, to October 11, 2031, subject to shareholder approval.

Mrs. Chetna holds an LLB from Jaipur School of Law, is a Company Secretary from the Institute of Company Secretaries of India, and holds an MBA in Finance. She is registered in the Independent Director Databank under the Indian Institute of Corporate Affairs with registration number IDDB-PA-202012-032734. The disclosure confirms no relationship exists between her and other Directors or Key Managerial Personnel.

Historical Stock Returns for ANG Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
+1.86%+7.98%+33.25%+112.33%+27.65%-84.61%

How might the re-appointment of Mr. Rohit Mittal and Mrs. Chetna signal changes in ANG Lifesciences' strategic direction or governance priorities for FY27?

What are the potential implications for shareholder voting patterns given the shift to a fully virtual AGM via VC/OAVM?

Could the appointment of M/s Shreya Sahu & Associates as Cost Auditor indicate any upcoming scrutiny on operational efficiency or cost management within the company?

More News on ANG Lifesciences

Must Read Next

Stocks

Aurobindo Pharma subsidiary Acrotech launches AdQuey ointment in US 11 mins ago
no imag found
Lemon Tree Hotels opens first 65-room Keys Prima in Darjeeling 34 mins ago
1 Year Returns:+27.65%